Determination of raltitrexed in human plasma by high performance liquid chromatography-electrospray ionization-mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 853, Issue 1-2, 2007, Pages 147-153

  Hu, Jingjing ^a   Ding, Li ^a   Song, Qinxin ^a   Gao, Ying ^b   Qing, Shukui ^c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Jiangsu Chia Tai Tianqing Pharmaceutical Co Ltd   (China)

^c The 81st Hospital of PLA   (China)

Author keywords

HPLC ESI MS; Pharmacokinetics; Raltitrexed

Indexed keywords

ELECTROSPRAY IONIZATION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHANOL; PHARMACOKINETICS;

CHROMATOGRAPHIC SEPARATION; INTERNAL STANDARD (IS); PROTEIN-FREE EXTRACTS; SELECTED ION MONITORING (SIM);

PLASMA (HUMAN);

ACETONITRILE; BENAZEPRILAT; FORMIC ACID; METHANOL; RALTITREXED; WATER;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHINESE; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION MONITORING; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MOLECULAR STRUCTURE; QUINAZOLINES; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; THIOPHENES;

EID: 34250010658     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.03.028     Document Type: Article

References (18)

1. Widemann B.C., Balis F.M., Godwin K.S., McCully C., and Adamson P.C. Cancer Chemother. Pharmacol. 44 (1999) 439
2. Clarke S.J., Beale P.J., and Rivory L.P. Clin. Pharmacokinet. 39 (2000) 429
3. Bendavid Y., Leblond F.A., and Dube P. Med. Sci. Moint. 11 (2005) BR1
4. Nguyen D., Emond C., Leclerc Y., Sherman I., and Dube P. Med. Sci. Monit. 9 (2003) BR37
5. Aherne G.W., Ward E., Lawrence N., Dobinson D., Clarke S.J., Musgrove H., Sutcliffe F., Stephens T., and Jackman A.L. Br. J. Cancer 77 (1998) 221
6. Grem J.L., Sorensen J.M., Cullen E., Takimoto C.H., Steinberg S.M., and Chen A.P. Clin. Cancer Res. 5 (1999) 2381
7. Blair E.Y., Rivory L.P., Clarke S.J., and McLachlan A.J. Br. J. Clin. Pharmacol. 57 (2004) 416
8. Beale P., Judson I., Hanwell J., Berry C., Aherne W., Hickish T., Martin P., and Walker M. Cancer Chemother. Pharmacol. 42 (1998) 71
9. Ferrero, Chamorey, Magne, Leccia, Largillier, Namer, and Milano. Cancer Chemother. Pharmacol. 50 (2002) 459
10. Wang D., Gao Y., and Yun L. Chin. J. Pharm. Anal. 25 (2005) 778
11. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM) May 2001.
12. Matuszewski K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 75 (2003) 3019
13. Snyder L.R., Kirkland J.J., and Glajch J.L. Practical HPLC Method Development (1997), John Wiley & Sons Inc., New York P.659
14. Ding L., Li L., Tao P., Yang J., and Zhang Z. J. Chromatogr. B 767 (2002) 75
15. Ding L., Huang X., Yang J., Bian X., Zhang Z., and Liu G. J. Pharm. Biomed. Anal. 40 (2006) 758
16. Ding L., Yang L., Liu F., Ju W., and Xiong N. J. Pharm. Biomed. Anal. 42 (2006) 213
17. Ding L., Hu J., Jiang M., and Xiong N. J. Chromatogr. B 843 (2006) 78
18. Ding L., Wei X., Zhang S., Sheng J., and Zhang Y. J. Chromatogr. Sci. 42 (2004) 254